The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from CNW Group

James B. Hickey, Jr. Joins IMRIS Board of Directors

Thursday, May 30, 2013

James B. Hickey, Jr. Joins IMRIS Board of Directors

17:30 EDT Thursday, May 30, 2013

WINNIPEG, MB, May 30, 2013 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced the appointment of James Hickey to the company's board of directors effective June 1, 2013.

Mr. Hickey is an experienced medical device industry executive who brings more than 25 years of experience in building, managing and leading successful medical technology companies.  He began his career with American Hospital Supply/Baxter Healthcare in 1977.  Subsequently he has served as the CEO of two publicly traded and two private medical device companies and is currently President and CEO of Phraxis, a medical device developer of vascular access products for the dialysis market. From 1998 until 2011, Mr. Hickey served on the board of Vital Images, including having served as the Chair of the Board.

"The addition of Jim to our board brings extensive industry knowledge and leadership experience that will benefit our company, our customers and our shareholders," said David Graves, Chairman of the Board of Directors.  "Jim's contribution to the strategic thinking in combination with his broad industry experience will make a meaningful difference to IMRIS."

Mr. Hickey has served on numerous medical device boards and was honored by Twin Cities Business Monthly as one of their "Corporate Directors of the Year" in 2005.

"I am delighted to join the IMRIS' board of directors," said Mr. Hickey.  "IMRIS' VISIUS® Surgical Theatre is the leading technology in the market, and with the development of the SYMBIS™ Surgical Robotic System, has the potential to improve outcomes for patients while reducing the cost of care.  I look forward to contributing to the growth of the company."

Mr. Hickey will replace Mr. Robert Courteau who has resigned from the board of directors effective May 31, 2013.


IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing image guided therapy solutions through its VISIUS Surgical Theatre - a revolutionary, multifunctional surgical environment that provides unmatched intraoperative vision to clinicians to assist in decision making and enhance precision in treatment. VISIUS Surgical Theatres serve the neurosurgical, cardiovascular and cerebrovascular markets and have been selected by leading medical institutions around the world.



For further information:

Kelly McNeill
Tel: 204-480-7090

  • Globe Unlimited

    Digital all access pass across devices. subscribe

  • The Globe and Mail Newspaper

    Newspaper delivered to your doorstep. subscribe

  • Globe2Go

    The digital replica of our newspaper. subscribe

  • Globe eBooks

    A collection of articles by the Globe. subscribe

See all Globe Products

Advertise with us

Your number one partner for reaching Canada's Influential Achievers. learn more

The Globe at your Workplace
Our Company
Customer Service
Globe Recognition
Mobile Apps
Other Sections